Cargando…
Erratum to: Dual HER2 blockade: preclinical and clinical data
No abstract. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-014-0468-9) contains supplementary material, which is available to authorized users.
Autores principales: | Patel, Tejal A, Dave, Bhuvanesh, Rodriguez, Angel A, Chang, Jenny C, Perez, Edith A, Colon-Otero, Gerardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303199/ https://www.ncbi.nlm.nih.gov/pubmed/25927825 http://dx.doi.org/10.1186/s13058-014-0468-9 |
Ejemplares similares
-
Dual HER2 blockade: preclinical and clinical data
por: Patel, Tejal A, et al.
Publicado: (2014) -
Erratum: An all-silicon single-photon source by unconventional photon blockade
por: Flayac, Hugo, et al.
Publicado: (2015) -
Erratum: the National Institutes of Health and guidance for reporting preclinical research
por: Moher, David, et al.
Publicado: (2015) -
Erratum to “Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data”
por: Kroeger, Nils, et al.
Publicado: (2013) -
Erratum to: The impact of glutamine supplementation on the symptoms of ataxia-telangiectasia: a preclinical assessment
por: Chen, Jianmin, et al.
Publicado: (2017)